drugset / Trial / NCT01222026

Systematic Treatment After Successful Surgical Treatment for Primary Hyperparathyroidism With Strontium Ranelate

NCT01222026

RandomizedParallel-groupTriple-blindTreatment

Summary

Patients with primary hyperparathyroidism (pHPT) with osteopenia and osteoporosis are treated with strontium ranelate/Ca+Vitamin-D or placebo/Ca+Vitamin D after successful surgical treatment of pHPT. Strontium ranelate/Ca + Vitamin-D helps to regain bone mass in patients with osteopenia or osteoporosis after successful parathyroidectomy for pHPT and results in higher gain of BMD than placebo treated patients.

Timeline

Start
2010-09
Primary completion
2014-12
Completion
2014-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Strontium Ranelate Small molecule 2 g
Comparator Calcium carbonate Other / unclassified 1000 mg
Comparator Vitamin D Other / unclassified 800 iu